Ethics D1a, GEN-Requirement: Independent Ethics Advisor appointed to participate in the independent external expert panel (D6.9)

Lead Contributor: Mira Zuidgeest (UMCU)

November 11, 2019

Ethical guidance for the Trials@Home project is built into the project in several manners. One request from the IMI during the grant negotiation phase was to include the appointment of an independent Ethics Advisor, to monitor the ethics issues involved in this project and how they are handled, as a separate Deliverable. As it was already planned within the project to set up an independent external expert panel, comprising of at least 4 members including ethicists, it has been agreed to keep the Independent Ethics Advisor as part of this independent external expert panel, but to report on the appointment of the Ethics Advisor as a separate deliverable.

Read the full report here
IMI
EFPIA
EU

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 831458. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Notes for editors – not for publication
If you would like more information, please contact the spokesperson at the UMC Utrecht.
Joris Prinssen: +31 6 2571 0234
press@umcutrecht.nl